Liraglutide Audit ABCD Edinburgh Spring 2014 - Poster

NICE guidelines versus clinical practice – GLP-1 receptor agonists in type 2 diabetes: the ABCD nationwide audits

KY Thong1, P Sen Gupta2, ML Cull2, KA Adamson3, DS Dove4, SV Rowles5, S Tarpey5, C Duncan6 , J Chalmers6, R Harper7, P McDonald7, U Brennan7, C Walton8, REJ Ryder2 on behalf of the ABCD Nationwide exenatide* and liraglutide audit contributors

1School of Medicine and Pharmacology University of Western Australia, Perth, Australia

2Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK

3St John’s Hospital, Livingston, UK

4Heatherwood and Wexham Park Hospitals NHS Foundation Trust, Wexham, UK

5Pennine Acute Hospitals NHS Trust, Greater Manchester, UK

6Victoria Hospital, Kirkcaldy, UK

7The Ulster Hospital, Dundonald, UK

8Hull Royal Infirmary, Hull, UK

*The exenatide audit contributors are listed in reference 2

The liraglutide audit contributors are listed in reference 3

Discipline: 
Diabetes
Clinical taxonomy: 
Treatments for diabetes
Type 2 diabetes mellitus
Resource taxonomy: 
Audit
Posters

Information for HCPs

COVID-19 Information for Healthcare Professionals

ABCD Webinar Series

ABCD Webinars